HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 9, 8197-8207, March 4, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: 280/9/8197    most recent M412021200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, L. A. Articles by Guan, J.-L. Search for Related Content PubMed PubMed Citation Articles by Cohen, L. A. Articles by Guan, J.-L. Social Bookmarking                      What's this?

Residues within the First Subdomain of the FERM-like Domain in Focal Adhesion Kinase Are Important in Its Regulation^*

Lee Ann Cohen and Jun-Lin Guan

From the Department of Molecular Medicine, Cornell University, Ithaca, New York 14853

We have previously described regulation of focal adhesion kinase (FAK) by its amino-terminal FERM-like domain through an autoinhibitory interaction with its kinase domain (Cooper, L. A., Shen, T. L., and Guan, J. L. (2003) Mol. Cell. Biol. 23, 8030–8041). Here we show that the first two subdomains of the FERM-like domain are independently capable of inhibiting phosphorylation of FAK in trans. We characterized several point mutations within the first subdomain of the FERM-like domain and find that mutation of Lys-38 to alanine results in a FAK mutant that is strongly hyperphosphorylated when expressed in mammalian cells, and promotes increased phosphorylation of the FAK substrate paxillin. A second mutation of Lys-78 to alanine results in a FAK mutant that is underphosphorylated, but can be activated by extracellular matrix stimuli. Like deletion of the amino terminus itself the K38A mutation is phosphorylated in suspension. The 375 truncation mutant of FAK is strongly phosphorylated both when Tyr-397 is mutated to phenylalanine, and in the presence of the Src inhibitor, PP2, suggesting that removal of the amino terminus can render FAK Src independent. This is in contrast to the K38A mutant that is not phosphorylated in the Y397F background, and which shows decreased phosphorylation in the presence of the Src inhibitor PP2, suggesting that regulation of FAK by Src is a secondary step in its activation. The K38A mutation weakens the interaction between the amino terminus of FAK and its own kinase domain, and disrupts the ability of the amino terminus to inhibit the phosphorylation of FAK in trans. The K38A mutation of FAK also increases the ability of FAK to promote cell cycle progression and cell migration, suggesting that hyperphosphorylation of this mutant can positively affect FAK function in cells. Together, these data strongly suggest a role for the first FAK subdomain of the FERM domain in its normal regulation and function in the cell.

Received for publication, October 22, 2004 , and in revised form, December 10, 2004.

^* This work was supported by National Institutes of Health Grant GM48050 (to J.-L. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 607-253-3586; Fax: 607-253-3708; E-mail: jg19{at}cornell.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. C. Loftus, Z. Yang, N. L. Tran, J. Kloss, C. Viso, M. E. Berens, and C. A. Lipinski The Pyk2 FERM domain as a target to inhibit glioma migration Mol. Cancer Ther., June 1, 2009; 8(6): 1505 - 1514. [Abstract] [Full Text] [PDF]

				E. Papusheva, F. Mello de Queiroz, J. Dalous, Y. Han, A. Esposito, E. A. Jares-Erijman, T. M. Jovin, and G. Bunt Dynamic conformational changes in the FERM domain of FAK are involved in focal-adhesion behavior during cell spreading and motility J. Cell Sci., March 1, 2009; 122(5): 656 - 666. [Abstract] [Full Text] [PDF]

				Y. Piao, L. Lu, and J. de Groot AMPA receptors promote perivascular glioma invasion via {beta}1 integrin-dependent adhesion to the extracellular matrix Neuro-oncol, January 1, 2009; 11(3): 260 - 273. [Abstract] [Full Text] [PDF]

				W.-C. Wei, H.-H. Lin, M.-R. Shen, and M.-J. Tang Mechanosensing machinery for cells under low substratum rigidity Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1579 - C1589. [Abstract] [Full Text] [PDF]

				X. Cai, D. Lietha, D. F. Ceccarelli, A. V. Karginov, Z. Rajfur, K. Jacobson, K. M. Hahn, M. J. Eck, and M. D. Schaller Spatial and Temporal Regulation of Focal Adhesion Kinase Activity in Living Cells Mol. Cell. Biol., January 1, 2008; 28(1): 201 - 214. [Abstract] [Full Text] [PDF]

				D. D. Schlaepfer, S. Hou, S.-T. Lim, A. Tomar, H. Yu, Y. Lim, D. A. Hanson, S. A. Uryu, J. Molina, and S. K. Mitra Tumor Necrosis Factor-{alpha} Stimulates Focal Adhesion Kinase Activity Required for Mitogen-activated Kinase-associated Interleukin 6 Expression J. Biol. Chem., June 15, 2007; 282(24): 17450 - 17459. [Abstract] [Full Text] [PDF]

				P. M.F. Siesser and S. K. Hanks The Signaling and Biological Implications of FAK Overexpression in Cancer. Clin. Cancer Res., June 1, 2006; 12(11): 3233 - 3237. [Full Text] [PDF]

				D. F. J. Ceccarelli, H. K. Song, F. Poy, M. D. Schaller, and M. J. Eck Crystal Structure of the FERM Domain of Focal Adhesion Kinase J. Biol. Chem., January 6, 2006; 281(1): 252 - 259. [Abstract] [Full Text] [PDF]